Correlation Between Abcellera Biologics and Simulations Plus

Can any of the company-specific risk be diversified away by investing in both Abcellera Biologics and Simulations Plus at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Abcellera Biologics and Simulations Plus into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Abcellera Biologics and Simulations Plus, you can compare the effects of market volatilities on Abcellera Biologics and Simulations Plus and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Abcellera Biologics with a short position of Simulations Plus. Check out your portfolio center. Please also check ongoing floating volatility patterns of Abcellera Biologics and Simulations Plus.

Diversification Opportunities for Abcellera Biologics and Simulations Plus

-0.95

Correlation Coefficient

Abcellera Biologics  Simulations Plus

Pay attention - limited upside

The 3 months correlation between Abcellera and Simulations is -0.95. Overlapping area represents the amount of risk that can be diversified away by holding Abcellera Biologics and Simulations Plus in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Simulations Plus and Abcellera Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Abcellera Biologics are associated (or correlated) with Simulations Plus. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Simulations Plus has no effect on the direction of Abcellera Biologics i.e., Abcellera Biologics and Simulations Plus go up and down completely randomly.

Pair Corralation between Abcellera Biologics and Simulations Plus

Given the investment horizon of 90 days Abcellera Biologics is expected to generate 1.0 times more return on investment than Simulations Plus. However, Abcellera Biologics is 1.0 times less risky than Simulations Plus. It trades about 0.26 of its potential returns per unit of risk. Simulations Plus is currently generating about -0.2 per unit of risk. If you would invest  203.00  in Abcellera Biologics on May 16, 2025 and sell it today you would earn a total of  247.00  from holding Abcellera Biologics or generate 121.67% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Abcellera Biologics  vs.  Simulations Plus

Abcellera Biologics

Risk-Adjusted Performance

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Abcellera Biologics are ranked lower than 20 (%) of all global equities and portfolios over the last 90 days. Despite quite weak fundamental indicators, Abcellera Biologics disclosed solid returns over the last few months and may actually be approaching a breakup point.

Simulations Plus

Risk-Adjusted Performance

Weakest

Over the last 90 days Simulations Plus has generated negative risk-adjusted returns adding no value to investors with long positions. Even with uncertain performance in the last few months, the Stock's essential indicators remain relatively invariable which may send shares a bit higher in September 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Pair Trading with Abcellera Biologics and Simulations Plus

The main advantage of trading using opposite Abcellera Biologics and Simulations Plus positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Abcellera Biologics position performs unexpectedly, Simulations Plus can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Simulations Plus will offset losses from the drop in Simulations Plus' long position.

The idea behind Abcellera Biologics and Simulations Plus pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.